FDA unlikely to rule on Merck's COVID pill before DecemberFDA unlikely to rule on Merck's COVID pill before DecemberFDA unlikely to rule on Merck's COVID pill before December

FDA unlikely to rule on Merck's COVID pill before December

The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck's pill to treat COVID-19.

from Section Page News - Modern Healthcare https://ift.tt/3vritKp